Our catheter and its application
Learn more about our catheter and its use, and benefit from our practical expertise.
Our systems enable safe home care for patients — to reduce hospital resources, improve quality of life, and sustainably reduce the burden on healthcare providers.
Whether treating ascites or pleural effusion, we are here to support you.
Pleural effussion
drainova® ArgentiC | Implantation for pleural effusion
This video provides a concise overview of treatment options for pleural effusion using indwelling catheter systems such as the drainova® ArgentiC catheter.
Practical Experience with IPC for Pleural Effusion
In this video, Dr. Bassam Redwan, Senior Consultant in thoracic surgery at the Knappschaft Clinics Lünen, demonstrates the implantation of an IPC in a patient with suspected pleural carcinomatosis during VATS (Video-Assisted Thoracoscopy).
Ascites
drainova® ArgentiC | Implantation for pleural effusion
In this video, PD Dr. Dr. med. David Semela, Dr. med. Irina Bergamin, and Dr. med. Pamela Meyer-Herbon from HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, provide a step-by-step demonstration of IPC implantation for ascites.
Our drainova® ArgentiC Catheter with Micro-Silver
The tunneled ArgentiC catheter enables repeated drainage for patients with recurrent malignant and non-malignant pleural effusion or ascites in both hospital and home settings.
The catheter is made of biocompatible silicone with embedded micro-silver. The silver ions provide antimicrobial activity on the catheter surface.
Features and Benefits
-
- For implantation in malignant and non-malignant pleural effusion and ascites
- Rapid and efficient symptom relief
- Reduction of infections
- Reduction of hospital stays
- Lower healthcare costs
- Single-use medical device
- Compatible with drainova®, ewimed, and PleurX™ drainage systems for hospital and home use
Get to know our ewimed Report 2025
Data-driven insights on the topic of IPCs
Therapy Data 2024:
Analysis of the ewimed patient questionnaire on implantation numbers, indications, and therapy decisions.
Literature Update:
Analysis of a recent study on resource use and the costs of IPC implantation compared with pleurodesis.
Infections in Non-Malignant Ascites:
A new study on silver-containing IPCs shows a significant reduction in infection risk. The report includes an expert interview with Prof. Dr. Benjamin Maasoumy of Hannover Medical School.
Sustainability in Healthcare:
International insights into the implementation of sustainable initiatives in European hospitals, complemented by an expert discussion with PD Dr. med. Stefan Welter (Lungenklinik Hemer) and Martina Moll (Sana Kliniken AG).
Practical Case Reports:
Two real-world case examples from Austria illustrating the use of IPCs both after a long disease course and shortly after diagnosis.